New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case

--:--
Flagship Asset Management fund manager, Philip Short
New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case
24 Jun 12PM English South Africa Business

Other recent episodes